Marcus Hompesch
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Science top 5%
Papers in
-
- Diabetes Treatment and Management 46
- Diabetes Management and Research 41
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
-
- Biosimilars and Bioanalytical Methods 6
- Co-authors
- Linda Morrow (39 shared papers)Lutz Heinemann (15 shared papers)Andrew J. Krentz (13 shared papers)Ken Fujioka (2 shared papers)Damayanthi Devineni (2 shared papers)Daniel E. Vaughn (4 shared papers)Douglas B. Muchmore (4 shared papers)An Vandebosch (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (20 papers)Diabetes Care (9 papers)Journal of Diabetes Science and Technology (8 papers)Diabetes (8 papers)Diabetes Technology & Therapeutics (7 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Marcus Hompesch
90 papers receiving 2.4k citations
Marcus Hompesch's Hit Papers
Peers
Comparison fields: 5 of 101
- Endocrinology, Diabetes and Metabolism 1.6k
- Pharmaceutical Science 76
- Pharmacology 146
- Nephrology 78
- Epidemiology 204
Countries citing papers authored by Marcus Hompesch
This map shows the geographic impact of Marcus Hompesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Hompesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Hompesch more than expected).
Fields of papers citing papers by Marcus Hompesch
This network shows the impact of papers produced by Marcus Hompesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Hompesch. The network helps show where Marcus Hompesch may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Hompesch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 250 | |
| 2 | 2012 | 197 | |
| 3 | 2016 | 150 | |
| 4 | 2016 | 145 | |
| 5 | 2006 | 115 | |
| 6 | 2011 | 92 | |
| 7 | 2005 | 85 | |
| 8 | 2017 | 77 | |
| 9 | 2016 | 71 | |
| 10 | 2023 | 69 | |
| 11 | 2011 | 65 | |
| 12 | 2014 | 62 | |
| 13 | 2012 | 52 | |
| 14 | 2008 | 51 | |
| 15 | 2020 | 49 | |
| 16 | 2004 | 48 | |
| 17 | 2019 | 46 | |
| 18 | 2019 | 41 | |
| 19 | 2013 | 40 | |
| 20 | 2011 | 39 |
About Marcus Hompesch
Marcus Hompesch is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology, Epidemiology, Pharmacology and Surgery, having authored 94 papers that have together received 2.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (46 papers), Diabetes Management and Research (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Biosimilars and Bioanalytical Methods (6 papers), Liver Disease Diagnosis and Treatment (4 papers), Pancreatic function and diabetes (4 papers), Pharmacology and Obesity Treatment (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Pharmaceutical Science (76 citations), Pharmacology (146 citations), Nephrology (78 citations) and Epidemiology (204 citations). Marcus Hompesch has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Linda Morrow, Lutz Heinemann, Andrew J. Krentz, Ken Fujioka, Damayanthi Devineni, Daniel E. Vaughn, Douglas B. Muchmore, An Vandebosch, Donna M. Skee and Kirk Ways. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes Care, Journal of Diabetes Science and Technology, Diabetes and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.